Missed Opportunities in Heart Failure Care: Supporting Early Diagnosis With Cardiac Biomarkers and Maximizing Treatment Potential With SGLT2 Inhibitors

Agenda:

7:15-Welcome, Assessment

7:18-Missed Opportunities in HF Diagnosis: Clinical Manifestations and Biomarkers For Early Detection

7:33-Missed Opportunities in HF Treatment: Optimizing GDMT in HF

8:03-Missed Opportunities in Patient-Centered Care: Strategies for Managing Treatment Side Effects Through Effective Counseling

8:13-Post-assessment and Evaluation

8:15-Question and Answer Session

8:30-Adjourn

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Heart Failure. 

Target Audience
This educational activity is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with heart failure.

Learning Objectives
Upon completion of this event, participants should be able to:

• Identify the clinical symptoms of heart failure (HF) and analyze the role of established and emerging cardiac biomarkers in its early identification and management
• Evaluate the efficacy, safety, and cardiovascular benefits of early and sustained SGLT2 inhibitor use in heart failure treatment
• Apply practical strategies to integrate SGLT2 inhibitors into personalized care plans for patients with heart failure across the spectrum on left ventricular ejection fraction